Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.
Explore The Range of Delivery Options for Your Molecule
This web tool enables drug development professionals to solve one of the most challenging aspects in drug development, determining the optimal finished dose suited to your specific product requirements, target indication and molecule properties.
Catalent Completes Acquisition of Accucaps, Expanding Global Softgel Capability
Catalent Pharma Solutions has completed the acquisition of Accucaps Industries Limited, the Canada-based developer and manufacturer of Over-the-Counter (OTC), high potency and conventional pharmaceutical softgels. The acquisition substantially complements Catalent’s global OTC and prescription pharmaceutical softgel development and manufacturing capabilities.
Our Solutions Improve Your Treatments at Every Stage
Catalent shares the passion to unlock the potential of your product, offering comprehensive solutions and superior technologies for oral, biologic, sterile and inhaled dose forms at every phase - from pre-clinical formulation through commercial supply.